145 related articles for article (PubMed ID: 31415427)
21. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
Dinicu AI; Dioun S; Wang Y; Huang Y; Wright JD; Tergas AI
Gynecol Oncol; 2024 May; 184():214-223. PubMed ID: 38340647
[TBL] [Abstract][Full Text] [Related]
22. Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study.
Sturdza AE; Pötter R; Kossmeier M; Kirchheiner K; Mahantshetty U; Haie-Meder C; Lindegaard JC; Jurgenliemk-Schulz I; Tan LT; Hoskin P; van Limbergen E; Gillham C; Segedin B; Tharavichitkul E; Iturre EV; Fokdal LU; Polterauer S; Kirisits C; Tanderup K
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):168-177. PubMed ID: 33932530
[TBL] [Abstract][Full Text] [Related]
23. High versus low-dose rate brachytherapy for cervical cancer.
Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
[TBL] [Abstract][Full Text] [Related]
24. Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.
Wright JD; Huang Y; Ananth CV; Tergas AI; Duffy C; Deutsch I; Burke WM; Hou JY; Neugut AI; Hershman DL
Gynecol Oncol; 2015 Dec; 139(3):506-12. PubMed ID: 26177552
[TBL] [Abstract][Full Text] [Related]
25. Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities.
Choi JY; Yeob KE; Hong SH; Kim SY; Jeong EH; Shin DW; Park JH; Kang GW; Kim HS; Park JH; Kawachi I
Cancer Control; 2021; 28():10732748211055268. PubMed ID: 35042390
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.
Lu DJ; Atkins KM; Small W; Kamrava M
Brachytherapy; 2022; 21(1):22-28. PubMed ID: 34895839
[TBL] [Abstract][Full Text] [Related]
27. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
28. Impact of age on receipt of curative treatment for cervical cancer: an analysis of patterns of care and survival in a large, national cohort.
Albert A; Lee A; Allbright R; Vijayakumar S
J Geriatr Oncol; 2019 May; 10(3):465-474. PubMed ID: 30361099
[TBL] [Abstract][Full Text] [Related]
29. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
[TBL] [Abstract][Full Text] [Related]
30. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
Robin TP; Amini A; Schefter TE; Behbakht K; Fisher CM
Gynecol Oncol; 2016 Nov; 143(2):319-325. PubMed ID: 27640961
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results.
Pinn-Bingham M; Puthawala AA; Syed AM; Sharma A; Disaia P; Berman M; Tewari KS; Randall-Whitis L; Mahmood U; Ramsinghani N; Kuo J; Chen WP; McLaren CE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):714-20. PubMed ID: 22763030
[TBL] [Abstract][Full Text] [Related]
32. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
[TBL] [Abstract][Full Text] [Related]
33. Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
McDaniels-Davidson C; Feng CH; Martinez ME; Canchola AJ; Gomez SL; Nodora JN; Patel SP; Mundt AJ; Mayadev JS
Cancer; 2022 Oct; 128(19):3479-3486. PubMed ID: 35917201
[TBL] [Abstract][Full Text] [Related]
34. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
35. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer survival for patients referred to a tertiary care center in Kentucky.
Seamon LG; Tarrant RL; Fleming ST; Vanderpool RC; Pachtman S; Podzielinski I; Branscum AJ; Feddock JM; Randall ME; Desimone CP
Gynecol Oncol; 2011 Dec; 123(3):565-70. PubMed ID: 21963092
[TBL] [Abstract][Full Text] [Related]
37. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis.
Stokes WA; Robin TP; Jackson MW; Amini A; Schefter TE; Lefkowits CC; Fisher CM
Am J Clin Oncol; 2018 Oct; 41(10):927-932. PubMed ID: 28654573
[TBL] [Abstract][Full Text] [Related]
39. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
40. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
